UAMY Insider Jon Marinelli Buys $93K of Stock
Jon Marinelli acquired 12,500 shares of United States Antimony at $7.45 each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Jon Marinelli bought 12,500 shares of United States Antimony Corporation ($UAMY) at an average price of $7.45, worth about $93,125, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $UAMY is up 4.3% after 1 week, down 20.9% after 1 month and down 61.9% to date (from the $7.48 close on Jun 15, 2026).
Key Points
- On June 15, 2026, Jon Marinelli bought 12,500 shares of United States Antimony Corporation at $7.45 each, totaling $93,125.
- United States Antimony, trading at $7.09, has a market cap of about $1.05 billion and a forward P/E ratio of 20.85.
- Recent insider activity includes several sales by company executives, while analysts maintain a strong buy consensus.
Get $UAMY trade alerts by text
We text you when insiders, Congress or big funds trade $UAMY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated United States Antimony Corporation alert may contain errors. Disclosures
Jon Marinelli, an insider at United States Antimony Corporation, purchased 12,500 shares of the company on June 15, 2026. The shares were bought at an average price of $7.45 each, amounting to a total value of $93,125. This transaction was not planned under a pre-arranged trading plan.
Other Institutional Activity in United States Antimony
VAN ECK ASSOCIATES CORP added a significant 10,369,695 shares, bringing its total to 10,369,695 shares valued at approximately $90.53 million. BLACKROCK, INC. increased its stake by 545,719 shares to a total of 9,883,038 shares worth about $86.28 million. STATE STREET CORP also added 378,051 shares, ending with 8,047,077 shares valued at $70.25 million. DRIEHAUS CAPITAL MANAGEMENT LLC significantly boosted its holdings by 4,052,162 shares, resulting in 5,345,710 shares valued at $46.67 million.
United States Antimony Corporation Stock Up 154.1%
Shares of United States Antimony Corporation (NYSE:UAMY) traded around $7.09. The company boasts a market capitalization of approximately $1.05 billion and a forward P/E ratio of 20.85, reflecting investor expectations of future earnings. The stock has a 52-week range between $1.94 and $19.71. It has a 50-day moving average of $9.41 and a 200-day moving average of $8.25. The company maintains a strong financial position with a current ratio of 3.62 and a quick ratio of 1.74.
Recent Earnings
United States Antimony reported revenues of $39.04 million, with a revenue decline of 3.1%. The company posted a negative net margin of 41.44% and a return on equity of -19.67%. The next earnings report is anticipated on August 14, 2026.
Insider Buying and Selling at United States Antimony Corporation
In addition to Jon Marinelli's recent purchase, there have been several insider sales. Richard Isaak, SVP and CFO, sold 100,000 shares at $9.75 on June 2, 2026. Lloyd Bardswich, Director and EVP, sold 59,872 shares at $8.98 on April 2, 2026. Melissa Pagen, President & COO of BRZ, sold 89,004 shares at $9.14 on March 23, 2026.
Analysts Set New Price Targets
On May 18, 2026, HC Wainwright & Co. maintained its buy rating on United States Antimony with a price target of $11.75. The consensus among analysts is a strong buy, with a mean target price of $13.06 based on four analyst opinions.
About United States Antimony Corporation
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada. The company operates in two main segments: Antimony and Zeolite. Its antimony products are used in flame retardants, batteries, and ammunition, while its zeolite is applied in a variety of industrial and environmental uses. The company, headquartered in Dallas, Texas, was founded in 1968 and is led by CEO Mr. Gary C. Evans.
Bottom Line
Jon Marinelli's recent purchase of United States Antimony shares highlights ongoing insider interest in the company. With a diverse product line and a strong buy analyst consensus, investors are closely watching this basic materials firm. As always, remember that insider trades are reported after the fact and may not reflect current positions.
Source: Jon Marinelli's Form 4 filing on $UAMY (Jun 15, 2026). Find the original filing: UAMY Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
